Highlights from the 58th Annual Scientific Sessions of the American College of Cardiology, March 28 to 31, 2009, Orlando, Florida

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 3, 2009, Pages 795-797

  Resnic, Frederic S ^a   Desai, Akshay ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; ROSUVASTATIN; WARFARIN;

AKINESIA; ANGIOGRAPHY; BARE METAL STENT; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DRUG ELUTING STENT; DYSKINESIA; EDITORIAL; FOLLOW UP; HEART ASSIST DEVICE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; LEFT CORONARY ARTERY; LOADING DRUG DOSE; MEDICAL SOCIETY; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; STROKE; TREATMENT OUTCOME; UNITED STATES; VALVULAR HEART DISEASE; VASCULAR SURGERY;

ATRIAL FIBRILLATION; CARDIOLOGY; CORONARY DISEASE; HEART FAILURE; HEART VALVE DISEASES; HUMANS; QUALITY OF LIFE; STENTS; STROKE; TREATMENT OUTCOME;

EID: 68749090990     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.06.008     Document Type: Editorial

References (14)

1. Serruys P., Maurice M.C., Kappetein P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2008) 961-972
2. Holmes D. PROTECT AF trial: randomized prospective trial of percutaneous LAA closure vs. warfarin for stroke prevention in AF. American College of Cardiology 2008 Scientific Sessions; Late Breaking Clinical Trials. March 28, 2009; Orlando, Fla.
3. Douglas P. Outcomes following coronary stenting: a national study of long term, real-world outcomes of bare-metal and drug-eluting stents. American College of Cardiology 2008 Scientific Sessions; Late Breaking Clinical Trials. March 28, 2009; Orlando, Fla.
4. Brigouri C. Impact of Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction (NAPLES II). American College of Cardiology 2008 Scientific Sessions; Late Breaking Clinical Trials. March 30, 2009; Orlando, Fla.
5. DiSciascio G. Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention (ARMYDA-RECAPTURE). American College of Cardiology 2008 Scientific Sessions; Late Breaking Clinical Trials. March 30, 2009; Orlando, Fla.
6. Jones R.H., Velazquez E.J., Michler R.E., et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 360 (2009) 1705-1717
7. Connolly SJ. Clopidogrel Plus Aspirin vs. Aspirin Alone for Prevention of Vascular Events in Patients with Atrial Fibrillation at High Risk of Stroke (ACTIVE A).American College of Cardiology 2008 Scientific Sessions; Late Breaking Clinical Trials. March 31, 2009; Orlando, Fla.
8. ACTIVE Investigators. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 360 (2009) 2066-2078
9. ACTIVE Writing Group of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367 (2006) 1903-1912
10. Holmes D. Percutaneous Left Atrial Appendage Closure vs. Warfarin for Stroke Prevention in Atrial Fibrillation (PROTECT AF). American College of Cardiology 2008 Scientific Sessions; Late Breaking Clinical Trials. March 28, 2009; Orlando, Fla.
11. Ridker P.M., Danielson E., Fonseca F.A.H., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207
12. Ridker P.M., Danielson E., Fonseca F.A.H., et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373 (2009) 1175-1182
13. Cheng D. Endovascular vs. Open Surgical Repair of Thoracic Aortic Disease (TEVAR). American College of Cardiology 2008 Scientific Sessions; Late Breaking Clinical Trials. March 30, 2009; Orlando, Fla.
14. Boyle A. The VentrAssist U.S. Pivotal Bridge to Cardiac Transplantation Trial. American College of Cardiology 2008 Scientific Sessions; Late Breaking Clinical Trials. March 30, 2009; Orlando, Fla.